BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/19/2022 12:49:59 AM | Browse: 856 | Download: 2074
Publication Name World Journal of Methodology
Manuscript ID 72756
Country Italy
ISSN 2222-0682 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Microscopy
Manuscript Type Observational Study
Article Title Lutetium in prostate cancer: Reconstruction of patient-level data from published trials and generation of a multi-trial Kaplan-Meier curve
Manuscript Source Unsolicited Manuscript
All Author List Andrea Messori
ORCID
Author(s) ORCID Number
Andrea Messori http://orcid.org/0000-0002-5829-107X
Funding Agency and Grant Number
Corresponding Author Andrea Messori, PharmD, Senior Researcher, HTA, ESTAR Toscana and Regione Toscana, via Alderotti 26/N, Firenze 50139, Italia, Italy. andrea.messori.it@gmail.com
Key Words Survival analysis; Individual patient data reconstruction; Kaplan-Meier curves; Meta-analysis; Prostate Cancer; Lutetium
Core Tip This paper describes the application of a new technique of individual-patient data reconstruction (IPDfromKM) to the progression-free survival curves published in two trials evaluating lutetium in metastatic prostate cancer. Our analysis interpreted these survival data and showed discordant results between the two trials, that need to be addressed by further clinical research.
Publish Date 2022-05-19 00:49
Citation Messori A. Lutetium in prostate cancer: Reconstruction of patient-level data from published trials and generation of a multi-trial Kaplan-Meier curve. World J Methodol 2022; 12(3): 107-112
URL https://www.wjgnet.com/2222-0682/full/v12/i3/107.htm
DOI https://dx.doi.org/10.5662/wjm.v12.i3.107
Full Article (PDF) WJM-12-107.pdf
Full Article (Word) WJM-12-107.docx